Cross-Channel rail owner to offer incentives for new operators
[ad_1] Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. The owner of the
Incentives for phase 1 clinical trials, cost advantage will help India to tap global opportunity: Parexel India MD Sanjay Vyas
[ad_1] Pharmaceutical industry in India is now looking beyond opportunities in the generics space and focusing on new avenues including biosimilars, contract manufacturing. India’s skillsets in
